» Articles » PMID: 28426202

Chemical Design and Synthesis of Functionalized Probes for Imaging and Treating Tumor Hypoxia

Overview
Journal Chem Rev
Specialty Chemistry
Date 2017 Apr 21
PMID 28426202
Citations 141
Authors
Affiliations
Soon will be listed here.
Abstract

Hypoxia development in tumor is closely associated with its increased aggressiveness and strong resistance to therapy, leading to the poor prognosis in several cancer types. Clinically, invasive oxygen microelectrode and high dosage radiotherapy are often utilized to accurately detect and effectively fight hypoxia. Recently, however, there has been a surge of interdisciplinary research aiming at developing functional molecules and nanomaterials that can be used to noninvasively image and efficiently treat hypoxic tumors. In this review, we will provide an overview of the reports published to date on the imaging and therapy of hypoxic tumors. First, we will present the design concepts and engineering of various hypoxia-responsive probes that can be applied to image hypoxia noninvasively, in an order of fluorescent imaging, positron emission tomography, magnetic resonance imaging, and photoacoustic imaging. Then, we will summarize the up-to-date functional nanomaterials which can be used for the effective treatments of tumor hypoxia. The well-established chemical functions of these elaborately designed nanostructures will enable clinicians to adopt specific treatment concepts by overcoming or even utilizing hypoxia. Finally, challenges and future perspectives facing the researchers in the field will be discussed.

Citing Articles

Aggregation control of anionic pentamethine cyanine enabling excitation wavelength selective NIR-II fluorescence imaging-guided photodynamic therapy.

Li Y, Qu F, Wan F, Zhong C, Rao J, Liu Y Nat Commun. 2025; 16(1):762.

PMID: 39824804 PMC: 11748625. DOI: 10.1038/s41467-024-55429-x.


A One Stone Three Birds Paradigm of Photon-Driven Pyroptosis Dye for Amplifying Tumor Immunotherapy.

Zeng S, Chen C, Yu D, Jiang M, Li X, Liu X Adv Sci (Weinh). 2025; 12(9):e2409007.

PMID: 39804952 PMC: 11884606. DOI: 10.1002/advs.202409007.


Engineered hypoxia-responsive albumin nanoparticles mediating mitophagy regulation for cancer therapy.

Wang W, Yao S, Luo J, Ding C, Huang Q, Yang Y Nat Commun. 2025; 16(1):596.

PMID: 39799105 PMC: 11724902. DOI: 10.1038/s41467-025-55905-y.


Advancements in nanotechnology-driven photodynamic and photothermal therapies: mechanistic insights and synergistic approaches for cancer treatment.

Shabnum S, Siranjeevi R, Raj C, Saravanan A, Vickram A, Chopra H RSC Adv. 2024; 14(52):38952-38995.

PMID: 39659608 PMC: 11629304. DOI: 10.1039/d4ra07114j.


NIR-II light-activated two-photon squaric acid dye with Type I photodynamics for antitumor therapy.

Wang K, Xu Y, Chen Z, Li H, Hu R, Qu J Nanophotonics. 2024; 11(22):5089-5100.

PMID: 39634301 PMC: 11501322. DOI: 10.1515/nanoph-2022-0482.